Noveltreat 0.25mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Noveltreat 0.25mg Injection
contains Semaglutide 0.25mg in a once-weekly subcutaneous auto-injector pen, manufactured by Knoll Pharma. This is the starting dose for Noveltreat injectable semaglutide therapy, designed to initiate GLP-1 receptor agonist treatment for weight management or type 2 diabetes with minimal gastrointestinal side effects before dose escalation. Noveltreat offers Indian-manufactured injectable semaglutide at a significantly more accessible price point than imported originator brands.
Benefits:
- Indian-manufactured injectable semaglutide at a fraction of imported brand prices
- Once-weekly subcutaneous injection for consistent GLP-1 receptor activation
- Low 0.25mg initiation dose to improve tolerance during the first 4 weeks
- Same active ingredient and mechanism as leading global injectable semaglutide brands
- Manufactured under DCGI-approved conditions by Knoll Pharma
How It Works:
Semaglutide binds GLP-1 receptors with high affinity and a prolonged half-life of approximately 7 days, enabling once-weekly dosing. At 0.25mg, the drug initiates receptor activation with partial occupancy, producing early insulin sensitisation, mild appetite modulation, and glucagon suppression — sufficient to condition the patient to higher therapeutic doses while minimising GI adverse effects.
Dosage and Administration:
Inject 0.25mg subcutaneously once weekly for 4 weeks into the abdomen, thigh, or outer upper arm. May be given at any time of day with or without food. Rotate injection sites. After 4 weeks, escalate to Noveltreat 0.5mg as directed. Each pen delivers multiple doses.
Side Effects:
Common: nausea, diarrhoea, vomiting, constipation, abdominal discomfort, decreased appetite. Injection-site: mild redness or bruising. Uncommon: increased heart rate. Serious: pancreatitis, diabetic retinopathy complications.
Precautions:
Contraindicated in personal or family history of medullary thyroid carcinoma or MEN2. Rotate injection sites each week. Do not share pens. Refrigerate unused pens.
Noveltreat Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 0.25mg | Lower strength option | 2–4 wks | Weekly | Current |
| 0.5mg | Standard strength option | 2–4 wks | Weekly | View → |
| 1mg | Popular strength option | 2–4 wks | Weekly | View → |
| 1.7mg | Higher strength option | 2–4 wks | Weekly | View → |
| 2.4mg | Maximum strength variant | 2–4 wks | Weekly | View → |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Noveltreat 0.25mg used for?
Noveltreat 0.25mg is the initiation dose of injectable semaglutide from Knoll Pharma, used for the first 4 weeks of GLP-1 therapy to allow the body to adjust before escalation to the therapeutic 0.5mg dose for weight management or type 2 diabetes.
Q2: How does Noveltreat compare to Ozempic?
Both Noveltreat and Ozempic contain semaglutide and work by the same GLP-1 receptor mechanism. Noveltreat is an Indian-manufactured generic version that offers the same clinical effect at a substantially lower cost per pen.
Q3: Is Noveltreat DCGI-approved?
Yes. Noveltreat injectable semaglutide from Knoll Pharma is approved by India's Central Drugs Standard Control Organisation (DCGI) for marketing and clinical use in India.
Q4: Why is Noveltreat much cheaper than Ozempic?
Noveltreat is manufactured in India with lower production costs and without the high R&D and global marketing expenses of the originator brand. Indian pricing regulations also support affordable access to essential medicines.
Q5: Can I switch from Ozempic to Noveltreat?
Yes, under prescriber guidance. The switch should occur at the same dose level. Both products contain semaglutide, and efficacy is equivalent based on bioequivalence data.
Q6: Does the Noveltreat pen need refrigeration?
Unused Noveltreat pens must be kept at 2–8°C. Once in use, the pen can be stored at room temperature (below 30°C) for up to 56 days, making it convenient for daily life without constant refrigeration.
Q7: What injection technique is used for Noveltreat?
Attach a new needle, select the 0.25mg dose dial, pinch a fold of skin at the clean injection site, insert the needle at 90°, press the injection button, and hold for 6 seconds before withdrawing. Dispose of the needle in a sharps container.
Q8: Can I use Noveltreat 0.25mg for weight loss without diabetes?
Prescribers may use injectable semaglutide off-label for weight management in patients without diabetes. For approved weight management, higher-dose semaglutide products (equivalent to Wegovy) are the indicated option.
Q9: What should I do if I miss a weekly Noveltreat injection?
Inject as soon as you remember, provided the next scheduled dose is more than 5 days away. If fewer than 5 days remain, skip the missed dose and resume on your next scheduled day. Do not double-dose.
Q10: Are there any special disposal requirements for Noveltreat pens?
Used pens with needles should be placed in a puncture-resistant sharps disposal container. Do not place in household waste. Contact your pharmacist for local sharps disposal information.
Customer Reviews
Global Meds Supply
Germany · 6 weeks ago
“Ordering from Medionix for several months now. Consistent pharmaceutical quality and professional service every time.”
Thomas B.
Australia · 4 months ago
“Legitimate pharmaceutical supplier. Packaging intact, expiry dates clearly printed, batch numbers traceable. Very satisfied.”
Robert Chen
Canada · 1 month ago
“Very satisfied with the order. Packaging was secure and delivery was on time. Quality matches the description perfectly.”
Dr. Emily Parker
UK · 2 months ago
“Impressed with the professionalism. Certificate of Analysis provided on request. Will be placing repeat orders for our clinic.”
Metro Hospital Pharmacy
UK · 2 weeks ago
“Reliable supplier. Product met all our quality standards. Great communication throughout the entire procurement process.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.